Free Trial

Victory Capital Management Inc. Has $13.69 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Victory Capital Management Inc. reduced its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 21.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 52,990 shares of the biotechnology company's stock after selling 14,290 shares during the quarter. Victory Capital Management Inc. owned approximately 0.07% of Axon Enterprise worth $13,689,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. BKM Wealth Management LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $32,000. Key Financial Inc boosted its position in shares of Axon Enterprise by 367.6% in the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company's stock valued at $41,000 after acquiring an additional 125 shares during the period. Lindbrook Capital LLC boosted its position in shares of Axon Enterprise by 43.3% in the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company's stock valued at $44,000 after acquiring an additional 52 shares during the period. Rakuten Securities Inc. acquired a new stake in shares of Axon Enterprise in the fourth quarter worth $48,000. Finally, GAMMA Investing LLC bought a new position in Axon Enterprise during the fourth quarter worth $83,000. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Price Performance

NASDAQ AXON traded down $5.66 during trading hours on Friday, reaching $303.43. 474,003 shares of the company's stock were exchanged, compared to its average volume of 532,478. The firm has a fifty day moving average of $310.64 and a 200-day moving average of $269.19. The company has a current ratio of 2.91, a quick ratio of 2.66 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The stock has a market cap of $22.90 billion, a PE ratio of 88.72 and a beta of 0.91.


Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm's quarterly revenue was up 34.3% compared to the same quarter last year. During the same period last year, the company posted $0.51 earnings per share. On average, equities research analysts predict that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on AXON shares. StockNews.com downgraded shares of Axon Enterprise from a "buy" rating to a "hold" rating in a report on Thursday, March 14th. Morgan Stanley lifted their price objective on Axon Enterprise from $285.00 to $310.00 and gave the stock an "equal weight" rating in a report on Friday, April 26th. The Goldman Sachs Group raised their target price on Axon Enterprise from $297.00 to $339.00 and gave the stock a "buy" rating in a research report on Wednesday, February 28th. Robert W. Baird boosted their price target on shares of Axon Enterprise from $260.00 to $300.00 and gave the company an "outperform" rating in a report on Thursday, February 22nd. Finally, JMP Securities reissued a "market outperform" rating and issued a $375.00 target price on shares of Axon Enterprise in a research note on Tuesday, May 7th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $335.27.

View Our Latest Analysis on Axon Enterprise

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

→ The Worst is Yet to Come… (From Porter & Company) (Ad)

Should you invest $1,000 in Axon Enterprise right now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Featured Articles and Offers

Search Headlines: